We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSMGW
376
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$15K ﹤0.01%
276,300
– –
ANGI icon
377
CALL
Angi Inc
ANGI
$182M
$14K ﹤0.01%
+7,850
New +$1.08M
AR icon
378
PUT
Antero Resources
AR
$11.6B
$14K ﹤0.01%
+275,000
New +$871K
ONC
379
PUT
BeOne Medicines Ltd
ONC
$40.6B
$14K ﹤0.01%
+5,500
New +$1.29M
DRNA
380
PUT
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$14K ﹤0.01%
+15,000
New +$311K
ABBV icon
381
CALL
AbbVie
ABBV
$442B
$12K ﹤0.01%
+39,700
New +$3.74M
CORT icon
382
PUT
Corcept Therapeutics
CORT
$12.1B
$12K ﹤0.01%
19,000
+1,500
+9% +$23.9K
LACQW
383
DELISTED
Leisure Acquisition Corp. Warrant
LACQW
$12K ﹤0.01%
25,060
– –
AIMT
384
CALL
DELISTED
Aimmune Therapeutics
AIMT
$12K ﹤0.01%
+156,200
New +$3.33M
BBIO icon
385
PUT
BridgeBio Pharma
BBIO
$16.4B
$11K ﹤0.01%
+5,000
New +$157K
CLF icon
386
PUT
Cleveland-Cliffs
CLF
$7.08B
$11K ﹤0.01%
29,700
-331,600
-92% -$2M
TEVA icon
387
CALL
Teva Pharmaceuticals
TEVA
$42.5B
$11K ﹤0.01%
+61,100
New +$646K
DCPH
388
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$11K ﹤0.01%
+15,000
New +$735K
ATNX
389
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
$11K ﹤0.01%
+925
New +$222K
XLRN
390
PUT
DELISTED
Acceleron Pharma
XLRN
$11K ﹤0.01%
+15,000
New +$1.49M
GIX.WS
391
DELISTED
GigCapital2, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $11.50
GIX.WS
$11K ﹤0.01%
11,902
-125,398
-91% -$93.7K
ADNWW
392
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$10K ﹤0.01%
+14,939
New +$7.52K
AMC icon
393
CALL
AMC Entertainment Holdings
AMC
$2.14B
$10K ﹤0.01%
+6,000
New +$300K
FITB
394
CALL
Fifth Third Bancorp
FITB
$52.2B
$10K ﹤0.01%
+7,900
New +$159K
LTRYW icon
395
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$755
$10K ﹤0.01%
28,166
-9,488
-25% -$3.2K
CSIQ icon
396
PUT
Canadian Solar
CSIQ
$1.08B
$9K ﹤0.01%
+45,000
New +$1.2M
MRK icon
397
PUT
Merck
MRK
$322B
$9K ﹤0.01%
+7,336
New +$575K
IMMU
398
CALL
DELISTED
Immunomedics Inc
IMMU
$9K ﹤0.01%
+58,800
New +$2.97M
ABUS icon
399
CALL
Arbutus Biopharma
ABUS
$923M
$8K ﹤0.01%
+25,000
New +$76K
AMC icon
400
PUT
AMC Entertainment Holdings
AMC
$2.14B
$8K ﹤0.01%
5,930
– –
14 15
16
17 18

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.